GLPG2737
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GLPG2737, covering 2018-03-19 to 2024-08-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 2]